Dennis J. Slamon

Director, Clinical & Translational Research at Jonsson Comprehensive Cancer Center

Dennis J. Slamon

Dennis J. Slamon

Director, Clinical & Translational Research at Jonsson Comprehensive Cancer Center

Overview
Career Highlights

Translational Research In Oncology

RelSci Relationships

1453

Number of Boards

5

Birthday

1949

Age

70

Number of Awards

3

Relationships
RelSci Relationships are individuals Dennis J. Slamon likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director, Nasal & Sinus Disease Center at University of California, Los Angeles - David Geffen School of Medicine

Relationship likelihood: Strong

Physician at Cedars-Sinai Medical Center

Relationship likelihood: Strong

Chief Executive Officer & President at BioMarin Pharmaceutical, Inc.

Relationship likelihood: Strong

Director, Shared Resources at Jonsson Comprehensive Cancer Center

Relationship likelihood: Strong

Director, Informatics at Jonsson Comprehensive Cancer Center

Relationship likelihood: Strong

Co-Founder at Enlibrium, Inc.

Relationship likelihood: Strong

Professor, Physiology at University of California, Los Angeles - David Geffen School of Medicine

Relationship likelihood: Strong

Chair, Department of Radiation Oncology at University of California, Los Angeles - David Geffen School of Medicine

Relationship likelihood: Strong

Vice Chair-Microbiology, Immunology & Molecular Genetics at University of California, Los Angeles - David Geffen School of Medicine

Relationship likelihood: Strong

Director, BioMedical Physics Interdepartmental Graduate Program at Jonsson Comprehensive Cancer Center

Relationship likelihood: Strong

Paths to Dennis J. Slamon
Potential Connections via
Relationship Science
You
Dennis J. Slamon
Director, Clinical & Translational Research at Jonsson Comprehensive Cancer Center
Education
MD
Class of 1975

The Pritzker School of Medicine is the M.D. granting unit of the Biological Sciences Division of the University of Chicago. It is located on the University's main campus in the historic Hyde Park neighborhood of Chicago, and matriculated its first class in 1927.As one of the most selective medical schools in the United States, it is currently ranked 10th among research universities for medical education by the US News & World Report.

Ph.D. in Cell Biology
Class of 1975

The University of Chicago's Office of Investments (COI) is responsible for managing the University's investment assets, which includes overseeing the endowment to ensure that it benefits both current and future generations of the University of Chicago. COI oversees the broad investment strategy and provides input to the development of the strategic and tactical investment policies of the University & UCMC endowments, pension plans and self-insurance trust assets. Their strategy combines qualitative and quantitative analysis, seeking to achieve superior investment performance on a risk-adjusted basis.COI's approach seeks to evaluate the investment strategy as an integrated part of the operating plans of the University rather than in isolation and focuses the the University's overall success, not investment returns. The endowment is well-diversified across a variety of asset classes, including global stocks and bonds, real estate, natural resources, private equity, absolute return strategies and protection (tail-hedging strategies). Asset class exposure is achieved primarily by selecting and engaging external managers. COI manages the global macro and the overlay portfolio to ensure that the portfolio's overall positioning is compliance with the endowment's investment guidelines.COI's strategies for investing in the public markets include: Absolute Return, Private Debt, Fixed Income and Credit. and Global Equities.COI's real assets team invests globally in real estate and natural resources using outside managers. The real estate portfolio invests globally in value-added and opportunistic strategies using both private partnerships and public vehicles. The natural resources portfolio invests globally in strategies that include, but are not limited to: oil and gas exploration & production; power generation; infrastructure; timber; mining and minerals; and agriculture.

B.A. Honors in Biology
Class of 1970

PROMOTE EDUCATION, THE DEVELOPMENT OF SKILLS, KNOWLEDGE, AND PERSONAL QUALITIES.

Memberships
Member, The Signal Transduction and Therapeutics Program Area
Current
Career History
Executive Vice Chair of Research, Department of Medicine
Current

The University of California, Los Angeles School of Medicine known as the David Geffen School of Medicine at UCLA, is an accredited medical school located in Los Angeles, California, USA.

Executive Director
2002 - Current
Director, Clinical & Translational Research
1991 - Current
Boards & Committees
Awards & Honors
2006
David A. Karnofsky Memorial Award
1981
Board Certification - American Board of Internal Medicine
1978
Board Certification - American Board of Internal Medicine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Dennis J. Slamon. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Dennis J. Slamon's profile does not indicate a business or promotional relationship of any kind between RelSci and Dennis J. Slamon.